![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 GIVOSIRAN SODIUM (1)
02 Givosiran (1)
03 LUMASIRAN (LUMASIRAN SODIUM) (1)
04 LUMASIRAN SODIUM (1)
05 PATISIRAN SODIUM (1)
06 Patisiran Sodium (1)
07 VUTRISIRAN (VUTRISIRAN SODIUM) (1)
08 VUTRISIRAN SODIUM (1)
01 ALNYLAM NETHERLANDS B.V (2)
02 ALNYLAM PHARMS INC (4)
03 Alnylam Pharmaceuticals (2)
01 SOLUTION (4)
02 SOLUTION;INTRAVENOUS (1)
03 SOLUTION;SUBCUTANEOUS (3)
01 189MG/ML (1)
02 25MG/0.5ML (1)
03 2MG/ML (1)
04 94.5MG/0.5ML (1)
05 EQ 10MG BASE/5ML (EQ 2MG BASE/ML) (1)
06 EQ 189MG BASE/ML (EQ 189MG BASE/ML) (1)
07 EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) (1)
08 EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML) (1)
01 Canada (4)
02 USA (4)